Recommendations for Individualized Rehabilitation of Syncope in Children and Adolescents during the COVID-19 Epidemic
Open Access
- 12 June 2020
- journal article
- Published by SciRes Literature LLC in Journal of Biomedical Research & Environmental Sciences
- Vol. 1 (2), 021-023
- https://doi.org/10.37871/jels1115
Abstract
Since December 2019, the outbreak of SARS-CoV-2 in WuHan, HuBei province, has spread to the whole country and abroad. As a susceptible population, the number of children and adolescents is increasing day by day. Under the severe situation of epidemic prevention and control, pediatric department has successively launched the expert consensus and treatment recommendations on the prevention and control of novel coronavirus pneumonia (COVID-19) in related fields. Syncope is a common emergency in children and adolescents, recurrent syncope seriously affects the quality of life and mental health of children. It is difficult for children with syncope to seek medical treatment during the epidemic period. This paper puts forward some Suggestions on the rehabilitation of children and adolescents with syncope during the epidemic period.Keywords
This publication has 7 references indexed in Scilit:
- Structure of dimeric full-length human ACE2 in complex with B0AT1Published by Cold Spring Harbor Laboratory ,2020
- Differential Diagnostic Models Between Vasovagal Syncope and Psychogenic Pseudosyncope in ChildrenFrontiers in Neurology, 2020
- 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescentsScience Bulletin, 2018
- Chloroquine‐induced cardiomyopathy: a reversible cause of heart failureESC Heart Failure, 2018
- Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and TreatmentCanadian Journal of Cardiology, 2014
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Journal of the American College of Cardiology, 2005